The Human Immunodeficiency Virus (HIV) has long been known to alter the clinical presentation of tuberculosis (TB), which varies according to the time of occurrence of TB infection and the level of immunodeficiency. Identifying variations in clinical features in HIV-TB coinfection might be helpful in settings with limited diagnostic facilities. The aim of this study was to assess the clinical presentation of TB in HIV coinfection and associate clinical findings with level of immune suppression (CD4 count).
Immune control of M. tuberculosis depends on both innate and adaptive cell-mediated immunity (14) .
Untreated HIV infection has been known to weaken the immune system either by severely depleting the CD4 cells (15) or by CD4 T-cell dysfunction as evidenced by reduced IL-2 or IFN-c production (16) , and this in turn increases susceptibility to infections, including TB. Thus, the incidence of TB in HIV-infected patients is closely correlated to the severity of immunosuppression (17) . 
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, and more prevalent extrapulmonary TB that too with concurrent pulmonary disease (3, 19) . 
Ethical Statement
Ethical clearance for the study was obtained from the Institutional ethical committee approved the study protocol. Written informed consent obtained from all the patients before participation in to the study.
Statistical Analysis
Continuous data was presented as mean (±SD) and 
RESULTS
In total 110 patients with co-infection of HIV and TB, most patients (42.7%) had CD4 counts between 101 to 200 ( Figure 1 ). Compared to females, males were affected more frequently with significant difference observed amongst groups (p=0.013), while the duration of combined illness did not vary significantly among the groups ( Table 1) . The demographic and essential medical history characteristics (Table 2 ) in three groups shows that mean age of the patients was not significantly different in three groups based on CD4 count. Lungs were the most common site of involvement (56.4%) followed next by combined pulmonary and extrapulmonary involvement (28.2%). Extra-pulmonary only involvement was infrequent with only few patients noted in three groups. There was no statistically significant difference observed for involvement of any site amongst three groups (P=0.700) ( Table 4 ). Frequency of sputum negative TB was higher in overall population as well as in three study groups. Though the difference in occurrence of sputum negative TB did not reach statistical significance among three groups (P=0.094), a considerably higher number of patients with CD4 counts below 100 had sputum negative TB (72%) as compared to sputum positive TB (28%). there is still a scarcity of such studies from India (26, 27) .
Patients in present study had a mean and median CD4+ count of 181.7cells/cumm and 156, respectively.
Median CD4 cell counts have ranged from < 150/cumm to > 300/cumm in previous reports of HIV-TB co-infected patients (28, 29) .
Almost one third (30%) of our patients had CD4 counts <100 cells/mm3, whereas more than two third (70 %) of the patients had CD4 counts <200 cells/mm3, similar to other recent observations (30) . In a study by Lee et extra-pulmonary TB while extra-pulmonary involvement was seen in a total of 43.7% patients. There was no statistically significant difference observed for involvement of any site amongst three groups (P=0.700) ( Table 4) . A study from the same region previously reported isolated pulmonary disease in 45%, extra-pulmonary disease in 25% and mixed in 30%, while the rates of extra-pulmonary involvement were higher than these in other studies ranging from 31% to 75.8% (27) . The explanation for this fact is probably HIV-positive patients who live in TB endemic areas, as is the case of the area where the present study was conducted, acquire TB either before HIV infection or earlier in the course of disease, when their immunity is still preserved, and more likely to develop typical forms of the disease e.g. pulmonary TB (26) .
Study from Hong-Kong observed 37% patients with pulmonary involvement alone, 13% had extra-pulmonary disease, and 50% had both pulmonary and extrapulmonary involvement (17) . Similarly, a study from USA also found only 38% of TB in the lungs alone, while 30% entirely extra-pulmonary and 32% both pulmonary and extrapulmonary (35). As immunosuppression worsens, HIV-infected patients may more often present with atypical features such as lymphadenopathy, pleural effusion, pericardial effusion, miliary TB, meningitis, and disseminated TB (24, 34) .
Studies have shown that tuberculous lymphadenopathy, both intra-and extra thoracic, remain the most frequent form of extrapulmonary TB (17) .
Similarly, we also found lymph node TB (16.4%) and pleural effusion (18.2%) followed by abdominal TB (5.5%).
Similarly Frieden et al. observed extra-pulmonary TB in lymph nodes (43%), pleura (23%), central nervous system (8%), and genitourinary tract (5%) patients (10). TB is often disseminated involving two or more non-contiguous organs/sites concomitantly, in patients with HIV (36). In our study 5.5% patients had disseminated TB in contrast to 25% patients in a study from Hong-Kong, probably due to the patient of that study had a significantly lower mean CD4 cell count (mean 40) (17).
TB, both pulmonary and extra-pulmonary were more prevalent in HIV patient who presented with lower CD4
cell counts (<200 cells/mm-3) at our institute, similar to previous observations (37) . Laboratory diagnosis of TB in HIV infected patients has been very challenging especially in poor resource settings because of scarcity of newer diagnostic methods. Because sputum smear remains the cornerstone of rapid diagnosis of TB in much of the world, even in areas of high HIV prevalence, including India. But the diagnostic accuracy of sputum smear microscopy is substantially impaired in patients with TB-HIV coinfection making diagnosis difficult (21) (22) , and its performance is even worst in patients with advanced immune suppression (18) .
Also due to operator dependence on sample collection and processing, and interpretation of sputum smears, the sensitivity of the sputum smear may vary greatly in resource-constrained settings (4). In our study population also, frequency of sputum negative TB was higher in overall population as well as in three study groups and sputum was positive for AFB smear in only 46.2% patients of pulmonary involvement. Thus, though the difference in occurrence of sputum negative TB did not reach statistical significance among three groups (p=0.094), a considerably higher number of patients with CD4 counts below 100 had sputum negative TB (72%) as compared to sputum positive TB (28%) ( Table 4 ). These smear-negative patients often are not diagnosed early, leading to higher mortality in such cases. Similar findings were observed by other authors who found sputum positivity ranging from 3 6 % to 61% The strengths of our study include analysis of clinical TB and also assessing these presentations across a resolution of CD4 strata than has not been previously published. A unique feature of our study was the assessment of clinical presentation of TB, whether pulmonary, extrapulmonary or combined, varying with the level of immune-suppression and correlation of these findings with CD4 levels, a feature previously not described.
Our study has some limitations also, including bias in patient selection. As our centre is a referral centre for the region, it is highly likely that patients with TB seen here, have more severe or clinically advanced disease due to delayed referral from peripheral areas. Selective referral for positive patients may explain the relatively low prevalence of AFB smear-negative PTB. As the symptom screening and sputum microscopy perform poorly in this group of patients, most requiring rapid TB diagnosis, chances are higher for misdiagnosis, this study may help somewhat in improvement in our understanding of the impact of gradual immunosuppression on the presentation of TB, which allows peripherally based clinicians to suspect their patients' likelihood of having TB earlier and thus reducing the diagnostic limitations in HIV-TB co-infected patients.
